ProAxsis Scientific Advisory Board

Penny Agent

Penny has worked at the Royal Brompton and Harefield NHS Foundation Trust since 1996 and is currently the Director of Rehabilitation and Therapies. Her professional background as a physiotherapist saw much of her career working in Cystic Fibrosis, where the Brompton hosts one of the largest CF services in Europe. Penny was the chair of the UK Association of Chartered Physiotherapists in CF from 2009-12 and is an internationally accredited (IPG/CF) airway clearance instructor. She maintains her clinical and research interest in CF, whilst working in a strategic, operational and leadership role.

Penny Agent

Director of Rehabilitation and Therapies at the Royal Brompton and Harefield NHS Foundation Trust

Stuart Elborn

Clinical Professor of Respiratory Medicine and Centre Director for Adult CF, Royal Brompton Hospital. Professor Elborn was one of the longest-serving Presidents of the European Cystic Fibrosis Society, holding the role between 2008 and 2015. His primary research

James Chalmers

Wellcome Trust Postdoctoral Fellow, Senior Clinical Lecturer and Honorary Consultant Respiratory Physician at the University of Dundee Dr Chalmers' group works on the interaction between neutrophils and bacteria in the lung with the aim of developing novel therapies and diagnostics for acute

Patrick Flume

Scott Sagel

Director of the University of Colorado CF Centre Dr Sagel is a pediatric pulmonologist who focuses on airway inflammation and lung disease in children with cystic fibrosis and primary ciliary dyskinesia.

Marcus Mall

Professor of Paediatrics / Director of the Department of Translational Pulmonology at the Heidelberg University Medical School / Head of Paediatric Pulmonology at the University Hospital Heidelberg. Prof. Mall's research is focused on the cellular and molecular pathogenesis of CF and other airways diseases, and the development of novel diagnostic approaches and